Welcome to our dedicated page for AEHR TEST SYSTEMS SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AEHR TEST SYSTEMS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AEHR TEST SYSTEMS's regulatory disclosures and financial reporting.
Aehr Test Systems (AEHR) has filed a Form 144, indicating a proposed sale of 18,000 common shares through Fidelity Brokerage Services. The shares have an aggregate market value of $356,972.22 and represent roughly 0.06% of the 29.77 million shares outstanding. The filer plans to execute the sale on or about 07/22/2025. The shares were acquired via an employee stock option granted on 08/17/2018 and are to be paid for in cash upon exercise. No other sales by the filer were reported during the past three months.
The notice contains no earnings data or operational updates; it simply alerts the market to a small potential insider transaction. Given the limited size relative to the company’s float, the filing is unlikely to be material to AEHR’s valuation or liquidity.
Aehr Test Systems (ticker AEHR) has filed a Form 144 indicating a planned sale of 3,000 common shares through Fidelity Brokerage Services on 15 July 2025. The proposed sale represents approximately 0.01 % of the company’s 29,771,410 shares outstanding and carries an aggregate market value of $42,390.
The shares to be sold were acquired via seven separate restricted-stock vesting events between 18 January 2024 and 11 January 2025, totaling exactly the 3,000 shares being registered. The filer reports no other sales in the past three months and affirms awareness of no undisclosed material adverse information about the company, in line with Rule 144 requirements.
Given the small size of the transaction relative to float and its origin from routine equity compensation, the filing is unlikely to be financially material for most investors, but it does add a data point to insider-trading dashboards.
Aehr Test Systems (AEHR) filed a Form 4 disclosing an insider equity transaction by President & CEO Gayn Erickson on 14 July 2025. The filing reports a Code F disposition of 4,518 common shares at an accounting price of $13.86 per share. Code F indicates the shares were withheld by the company to satisfy tax obligations triggered by the vesting of restricted stock units (RSUs) and restricted shares; it is not an open-market sale.
Following the withholding, Erickson’s direct ownership stands at 272,511 shares, while an additional 291,088 shares are held indirectly through a trust, for an aggregate insider position of roughly 563,599 shares. No derivative securities were acquired or disposed of, and no 10b5-1 trading plan was indicated.
The transaction represents a minor 0.8% reduction of Erickson’s total reported holdings and is routine for RSU vesting events. Investors typically view Code F tax-withholding transactions as neutral because they do not reflect an active decision to sell in the open market.
Aehr Test Systems (AEHR) filed a Form 4 showing an insider administrative share transaction. Executive VP of Sales & Marketing Vernon Rogers had 1,058 common shares withheld on 14-Jul-2025 to cover payroll taxes triggered by the vesting of restricted stock units (Transaction Code F). The shares were valued at $13.86 each, implying a tax-settlement value of roughly $14,665. This was not an open-market sale; it simply reduced the executive’s stake used for tax remittance. Following the withholding, Rogers continues to hold 68,578 AEHR shares, which still includes unvested RSUs. No derivative securities were reported. The filing does not indicate any change in strategic outlook or corporate fundamentals; it is a routine compliance event that should have minimal market impact.
Aehr Test Systems (AEHR) – Form 4 insider filing: Chief Technology Officer Donald P. Richmond II had 811 common shares withheld on 14 Jul 2025 (Transaction Code F) to cover tax obligations triggered by the vesting of restricted stock units (RSUs) at an indicated price of $13.86 per share. The filing explicitly notes that this is not an open-market sale; the shares were surrendered back to the issuer. After the withholding, Richmond still beneficially owns 214,694 shares, a figure that includes unvested RSUs. No derivative securities were reported, and there were no purchases or discretionary sales. Given the small number of shares involved (≈0.4 % of the insider’s holdings) and the routine nature of tax-related withholding, the transaction is viewed as administrative and immaterial to the company’s investment thesis.